📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. (2017)

First Author: Read ML

Attributed to: IMPROVING RADIOIODINE TREATMENT OF THYROID AND OTHER TUMOURS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2017.154

PubMed Identifier: 28504713

Publication URI: http://europepmc.org/abstract/MED/28504713

Type: Journal Article/Review

Volume: 36

Parent Publication: Oncogene

Issue: 37

ISSN: 0950-9232